National Cancer Institute / Phase II SBIR (R44CA239940)

Government

Part of National Cancer Institute

The National Cancer Institute is the U.S. federal government's principal agency for cancer research, funding early-stage biomedical companies through its SBIR/STTR grant and contract program to advance cancer detection, treatment, and prevention technologies.

Rockville · 1+ investments

Biotech
Headquarters
Rockville
Founded
1937
Website
cancer.gov
Total Investment
1
Last Investment
Sep 2021
Geographic Focus
United States

Investment Thesis

Funds small businesses developing innovative, high-risk cancer research technologies through non-dilutive Phase I and Phase II SBIR grants and contracts.

National Cancer Institute / Phase II SBIR (R44CA239940) is a Government firm based in Rockville. It has made 1 investment in Biotech.

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

National Cancer Institute / Phase II SBIR (R44CA239940) on Indexed.vc
<a href="https://indexed.vc/investors/national-cancer-institute-phase-ii-sbir-r44ca239940"><img src="https://indexed.vc/api/badge/investor/national-cancer-institute-phase-ii-sbir-r44ca239940" alt="National Cancer Institute / Phase II SBIR (R44CA239940) on Indexed.vc" width="260" height="76" /></a>